India Emerging As The Most Preferred Destination For Clinical Trials, Finds Netscribes’ Report

July 2, 2009 - PRLog -- Netscribes (India) Pvt. Ltd., a knowledge consulting solutions company, announces the launch of its report Clinical Trials Market – India. Low cost of trials, prevalence of variety of diseases, sound medical infrastructure and adherence to international quality standards has made India an ideal destination for clinical trials. Many domestic and foreign pharmaceutical companies have tied up with specialist research companies for the development of new drugs and conducting clinical trials.

The report begins with an overview of clinical trial market in India including market size, number of trials conducted and phase-wise breakup of clinical trials. The report highlights the key drivers and briefly analyzes the major issues/challenges hindering the growth of clinical trials market. The report covers the various government regulations outlining the legal and regulatory framework for conducting clinical trials in India. Competitive landscape identifies major Clinical Research Organizations and Research Institutes in India including the area of research and business outlook for each player. The report also covers the details of the private equity investments and key developments in clinical trials market in India.

For more details on the content of each report and ordering information please contact:

Natasha Mehta, CFA   
Tel: +65-9651-6382
Email: natasha.mehta@netscribes.com

Gagan Uppal
Tel: +91-98364-71499
Email: gagan.uppal@netscribes.com

# # #

About Netscribes (India) Pvt. Ltd.

Netscribes (www.netscribes.com) is a pioneering knowledge consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, publishing services and customized knowledge database creation. At its core lies a true value proposition that draws upon a vast knowledge base.

For more information please write to info@netscribes.com.